Relmada Therapeutics | 8-K:重大事件
Relmada Therapeutics | 4:持股變動聲明-高管 TRAVERSA SERGIO
Relmada Therapeutics | 4:持股變動聲明-高管 Shenouda Maged
Relmada Therapeutics | 4:持股變動聲明-董事 Kelly Paul Edward
Relmada Therapeutics | 4:持股變動聲明-董事 GLASSPOOL JOHN
Relmada Therapeutics | 4:持股變動聲明-董事 Fedeli Fabiana
Relmada Therapeutics | 4:持股變動聲明-高管 Ence Chuck
Relmada Therapeutics | 4:持股變動聲明-董事 CASAMENTO CHARLES J
Relmada Therapeutics | 10-Q:季度報表
Relmada Therapeutics | DEFA14A:其他
Relmada Therapeutics | DEF 14A:股東委託書決議
Relmada Therapeutics | 8-K:Relmada Therapeutics提供公司最新情況並報告2023年第四季度和全年財務業績
Relmada Therapeutics | 10-K:年度報表
Relmada Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(0.0%),Joseph Edelman(0.0%)等
Relmada Therapeutics | 144:擬議出售證券
Relmada Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(6.79%),Deep Track Biotechnology Master Fund, Ltd.(6.79%)等
Relmada Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RTW Investments, LP(0%),Roderick Wong, M.D.(0%)
Relmada Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.35%)
Relmada Therapeutics | 4:持股變動聲明-高管 TRAVERSA SERGIO
Relmada Therapeutics | 4:持股變動聲明-高管 Shenouda Maged
暫無數據